
Evelyn Y. Pyla
Examiner (ID: 11592, Phone: (571)270-7366 , Office: P/1651 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1651, 1633, 4141 |
| Total Applications | 649 |
| Issued Applications | 307 |
| Pending Applications | 80 |
| Abandoned Applications | 273 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19374884
[patent_doc_number] => 12066445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => System and method for cell levitation and monitoring
[patent_app_type] => utility
[patent_app_number] => 17/169765
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 58
[patent_no_of_words] => 12229
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169765 | System and method for cell levitation and monitoring | Feb 7, 2021 | Issued |
Array
(
[id] => 20328398
[patent_doc_number] => 12458655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section
[patent_app_type] => utility
[patent_app_number] => 17/166547
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5342
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166547 | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section | Feb 2, 2021 | Issued |
Array
(
[id] => 18434326
[patent_doc_number] => 20230181620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITIONS FOR TRANSLATION AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/795915
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795915 | COMPOSITIONS FOR TRANSLATION AND METHODS OF USE THEREOF | Jan 28, 2021 | Pending |
Array
(
[id] => 20185857
[patent_doc_number] => 12396957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Cell lines and their use in encapsulated cell biodelivery
[patent_app_type] => utility
[patent_app_number] => 17/145877
[patent_app_country] => US
[patent_app_date] => 2021-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 13550
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145877 | Cell lines and their use in encapsulated cell biodelivery | Jan 10, 2021 | Issued |
Array
(
[id] => 18207097
[patent_doc_number] => 20230053353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => TARGETING TRANSFER RNA FOR THE SUPPRESSION OF NONSENSE MUTATIONS IN MESSENGER RNA
[patent_app_type] => utility
[patent_app_number] => 17/791498
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -73
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791498 | TARGETING TRANSFER RNA FOR THE SUPPRESSION OF NONSENSE MUTATIONS IN MESSENGER RNA | Jan 7, 2021 | Abandoned |
Array
(
[id] => 20593881
[patent_doc_number] => 12577585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Compositions and methods of use of oncolytic virus like vesicles
[patent_app_type] => utility
[patent_app_number] => 17/791873
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 31
[patent_no_of_words] => 10485
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791873 | Compositions and methods of use of oncolytic virus like vesicles | Jan 7, 2021 | Issued |
Array
(
[id] => 16748922
[patent_doc_number] => 20210100931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => METHODS FOR STABILIZING A BIOPROSTHETIC TISSUE BY CHEMICAL MODIFICATION OF ANTIGENIC CARBOHYDRATES
[patent_app_type] => utility
[patent_app_number] => 17/127281
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127281 | Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates | Dec 17, 2020 | Issued |
Array
(
[id] => 17982893
[patent_doc_number] => 20220348929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => CRISPR ABASIC RESTRICTED NUCLEOTIDES AND CRISPR ACCURACY VIA ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/725324
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725324 | CRISPR ABASIC RESTRICTED NUCLEOTIDES AND CRISPR ACCURACY VIA ANALOGS | Dec 7, 2020 | Pending |
Array
(
[id] => 20547682
[patent_doc_number] => 12558455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-24
[patent_title] => Biologic composition and method of use
[patent_app_type] => utility
[patent_app_number] => 17/114896
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 0
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114896 | Biologic composition and method of use | Dec 7, 2020 | Issued |
Array
(
[id] => 19490554
[patent_doc_number] => 12109239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof
[patent_app_type] => utility
[patent_app_number] => 17/114685
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 36
[patent_no_of_words] => 22580
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114685
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114685 | Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof | Dec 7, 2020 | Issued |
Array
(
[id] => 18673212
[patent_doc_number] => 20230310706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => BURN RESTORATION MATERIAL
[patent_app_type] => utility
[patent_app_number] => 18/021864
[patent_app_country] => US
[patent_app_date] => 2020-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021864
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021864 | BURN RESTORATION MATERIAL | Nov 29, 2020 | Pending |
Array
(
[id] => 18390283
[patent_doc_number] => 20230158501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => 3D-Gerust aus biokompatiblem Polymer mit einem nach oben offenen Besiedlungsraum fur biologische Zellen und mit einem den Besiedlungsraum umgebenden kanalformigen Gefass
[patent_app_type] => utility
[patent_app_number] => 17/779991
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779991 | 3D scaffold comprising a biocompatible polymer with a colonization chamber open at the top for biological cells, and with a canal vessel surrounding the colonization chamber | Nov 19, 2020 | Issued |
Array
(
[id] => 20227342
[patent_doc_number] => 12415985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
[patent_app_type] => utility
[patent_app_number] => 17/097023
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 17
[patent_no_of_words] => 19969
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17097023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/097023 | Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state | Nov 12, 2020 | Issued |
Array
(
[id] => 19793507
[patent_doc_number] => 12234441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Cell expansion
[patent_app_type] => utility
[patent_app_number] => 17/087571
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 57
[patent_no_of_words] => 57297
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/087571 | Cell expansion | Nov 1, 2020 | Issued |
Array
(
[id] => 20433406
[patent_doc_number] => 12503683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Porous glucomannan scaffolds and methods for producing the scaffolds
[patent_app_type] => utility
[patent_app_number] => 17/081991
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 4857
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/081991 | Porous glucomannan scaffolds and methods for producing the scaffolds | Oct 26, 2020 | Issued |
Array
(
[id] => 16750167
[patent_doc_number] => 20210102176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => PERSONALIZED CELLS, TISSUES, AND ORGANS FOR TRANSPLANTATION FROM A HUMANIZED, BESPOKE, DESIGNATED-PATHOGEN FREE, (NON-HUMAN) DONOR AND METHODS AND PRODUCTS RELATING TO SAME
[patent_app_type] => utility
[patent_app_number] => 17/079821
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 577
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/079821 | Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same | Oct 25, 2020 | Issued |
Array
(
[id] => 16621800
[patent_doc_number] => 20210040453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => METHOD FOR MANUFACTURING STEM CELL HAVING APPROPRIATE SIZE FOR INTRAVASCULAR ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/080128
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080128
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080128 | METHOD FOR MANUFACTURING STEM CELL HAVING APPROPRIATE SIZE FOR INTRAVASCULAR ADMINISTRATION | Oct 25, 2020 | Abandoned |
Array
(
[id] => 18964415
[patent_doc_number] => 11898167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Reversible stencils for fabricating micro-tissues
[patent_app_type] => utility
[patent_app_number] => 17/079720
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 98
[patent_no_of_words] => 23573
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/079720 | Reversible stencils for fabricating micro-tissues | Oct 25, 2020 | Issued |
Array
(
[id] => 18647983
[patent_doc_number] => 20230293766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => WOUND CONTACT MEMBER
[patent_app_type] => utility
[patent_app_number] => 18/017209
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017209 | WOUND CONTACT MEMBER | Oct 21, 2020 | Pending |
Array
(
[id] => 16612035
[patent_doc_number] => 20210030688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => COATED BIOLOGICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/072625
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/072625 | Coated biological composition | Oct 15, 2020 | Issued |